Stock listing

BIST:DEVA Deva Holding A.S. Hisse

Follow Deva Holding A.S. into a list and get an email when it puts out news.

Share price · BIST:DEVA

70.00 TRY -2.30 (-3.2%)

Close on Nov 20, 2026

Past year +10.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
69.40 – 70.75 TRYNov 20, 2026
Volume
181,162 sharesNov 20, 2026
Market cap
14.00B TRYAt the close on Nov 20, 2026 · price × 200.0M shares outstanding
52-week range
57.50 – 109.30 TRYLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
51.74M TRYMedian day 356,363 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Deva Holding A.S. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · BIST:DEVA · TRY, adjusted for splits

DayCloseChange%OpenHighLowVolume
70.00-2.30-3.2%70.6070.7569.40181,162
72.30-1.55-2.1%74.1074.4072.00160,644
73.85-1.30-1.7%75.0076.2073.80243,633
75.15-2.00-2.6%77.1078.3075.15318,712
77.15-1.15-1.5%78.3579.6577.00268,004
78.30+2.50+3.3%75.0578.7574.85356,363
75.80-2.00-2.6%77.8078.1575.55366,508
77.80-1.60-2.0%80.8080.8077.50352,265
79.40-1.10-1.4%85.0087.2078.601,052,267
80.50+1.70+2.2%79.4581.1576.90364,196
78.80+5.80+7.9%73.1078.8073.10920,638
73.00+1.75+2.5%70.3074.8570.30681,407
71.25+0.55+0.8%70.7072.0069.05248,120
70.70+1.45+2.1%69.2071.4566.65347,283
69.25-1.25-1.8%69.9070.7568.45197,222
70.50-1.60-2.2%71.5572.1069.35139,185
72.10-1.35-1.8%73.4573.4570.85321,499
73.45+0.90+1.2%72.3573.6572.10165,002
72.55-0.10-0.1%72.9573.4069.70264,757
72.65-1.00-1.4%73.6573.7571.50306,600
73.65-3.45-4.5%77.3077.3073.60304,756
77.10+1.50+2.0%75.6077.2074.50353,944
75.60-0.75-1.0%75.9577.5074.85337,008
76.35-1.75-2.2%77.1077.1575.05191,695
78.10-1.10-1.4%78.1079.1077.05245,816
79.20-1.75-2.2%80.8080.8078.55357,364
80.95-2.05-2.5%82.6583.2580.15306,702
83.00-2.85-3.3%85.8586.2582.80305,832
85.85-1.15-1.3%87.3588.3085.15241,601
87.00+1.00+1.2%85.9087.3085.40164,729
86.00-1.35-1.5%86.6087.7584.50206,690
87.35-2.20-2.5%88.6089.8087.10204,652
89.55+0.55+0.6%88.9590.0087.55297,509
89.00-3.00-3.3%92.7093.3089.00326,377
92.00+1.90+2.1%90.7592.3089.25343,689
90.10-1.95-2.1%91.3594.2088.60318,002
92.05-1.20-1.3%93.2595.3091.80242,489
93.25-4.50-4.6%96.7596.8593.20207,132
97.75+1.75+1.8%96.7097.7595.40251,269
96.00-5.40-5.3%101.10101.7096.00356,893
101.40-0.80-0.8%101.00103.1099.50449,313
102.20+5.50+5.7%96.20102.2096.20528,399
96.70-2.40-2.4%97.5097.5093.90569,070
99.10-0.80-0.8%99.90101.3097.10680,352
99.90+5.70+6.1%94.0599.9093.10670,103
94.20-3.00-3.1%95.4597.3591.60704,330
97.20-7.00-6.7%102.10104.1097.05893,584
104.20+1.60+1.6%104.00108.40100.402,048,244
102.60-2.50-2.4%105.10109.30101.801,949,654
105.10+9.55+10.0%95.55105.1094.352,802,890
95.55-0.25-0.3%95.8097.4594.05552,537
95.80+1.50+1.6%94.9596.2594.30375,753
94.30+1.85+2.0%92.4595.5092.45606,783
92.45+1.90+2.1%90.6093.0090.60492,665
90.55-4.45-4.7%95.7096.3089.65702,814
95.00-0.65-0.7%95.5095.8593.25593,305
95.65+2.00+2.1%93.2595.7592.15953,183
93.65+2.05+2.2%93.3094.1092.15866,616
91.60+1.10+1.2%91.0593.5090.00453,980
90.50-0.80-0.9%92.7092.7089.60545,911
91.30+2.90+3.3%87.6092.2087.301,229,149
88.40+4.10+4.9%84.3089.6083.701,355,694
84.30+0.30+0.4%84.4585.8082.85800,539
84.00-5.15-5.8%89.5590.0082.751,510,388
89.15+3.95+4.6%85.2590.8084.352,121,798

Splits

6 splits since 2000 · BIST:DEVA · every price before a split is adjusted for it

DayRatioWhat
79-for-74Split
76-for-65Split
113-for-51Split
1-for-1000Consolidation
179-for-54Split
227-for-85Split
Ticker
BIST:DEVA
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
BIST
Currency
TRY

Deva Holding A.S. on 6ix

Sector
Health care
Industry
Pharmaceuticals
Decks
2 decks · latest October 2014

Valuation

EV/sales 0.6× against a median of 2.8×: 2nd lowest of 11 Pharmaceuticals companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
12.39B TRY
P/E
Loss
EV/sales
0.6×
EV/EBITDA
4.4×
Price/book
0.4×
Gross margin
38.2%
Operating margin
5.6%
Net margin
−3.9%
Debt to equity
0.1×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Deva Holding A.S. · BIST:DEVAUS$276.9MUS$245.0Mn/a0.6×4.4×0.4×−3.9%0.1×n/a
Hainan Huluwa Pharmaceutical Group Co. Ltd. Class A · SSE:605199US$287.7MUS$344.3Mn/a3.8×n/a7.2×−68.9%1.5×n/a
Chengdu Huasun Technology Group Inc., Ltd. Class A · SZSE:000790US$285.5MUS$277.5Mn/a4.4×n/a2.7×−57.2%0.1×n/a
Tiansheng Pharmaceutical Group Co. Ltd. Class A · SZSE:002872US$279.7MUS$239.5Mn/a3.1×n/a1.0×−10.6%0.0×n/a
Bukwang Pharmaceutical Co., Ltd. · KRX:003000US$278.7MUS$153.0M42.7×1.0×n/a1.1×4.1%0.0×n/a
Ildong Pharmaceutical Co., Ltd. · KRX:249420US$278.0MUS$233.1M8.6×0.5×6.3×1.4×7.5%0.0×n/a
Honz Pharmaceutical Co., Ltd. Class A · SZSE:300086US$276.0MUS$298.2Mn/a5.9×n/a2.2×−62.4%0.2×n/a
Shandong Sito Bio-technology Co., Ltd. Class A · SZSE:300583US$272.2MUS$254.6M62.3×1.5×n/a1.0×2.6%0.1×n/a
Lavipharm SA · ATHEX:LAVIUS$271.0MUS$309.0M41.2×4.5×22.8×4.4×9.6%0.7×n/a
Zhejiang East Asia Pharmaceutical Co., Ltd. Class A · SSE:605177US$264.1MUS$340.3Mn/a2.4×n/a1.1×−21.8%0.5×n/a
Jilin Jian Yisheng Pharmaceutical Co., Ltd. Class A · SZSE:002566US$260.3MUS$189.9M66.4×2.1×n/a0.8×4.4%0.1×n/a
Median of the othersUS$277.0MUS$266.0M42.7×2.8×14.5×1.3×−4.0%0.1×

Team and board

Officers

OfficerRole
Philipp HaasChairman of the Board & CEO
Mesut ÇetinChief Financial Officer

Board

DirectorRole
Philipp HaasChairman of the Board & CEO

Events

QuarterResultsShare move
Q1 2026May 7, 2026 · After close+3.4%
Q3 2025Nov 6, 2025 · After close−1.3%
Q1 2025May 9, 2025 · After close−1.4%
Q4 2024Feb 28, 2025+1.6%
Q3 2024Nov 8, 2024−1.4%
Q2 2024Aug 9, 2024−4.0%
Q1 2024Jun 24, 2024−12.1%
Q3 2023Nov 2, 2023 · Before open+5.4%
Q2 2023Aug 10, 2023 · Before open+0.7%
Q1 2023May 4, 2023 · Before open+0.1%
All 19 quarters
QuarterResultsShare move
Q4 2022Mar 2, 2023 · Before open+2.7%
Q3 2022Nov 4, 2022 · Before open+1.4%
Q2 2022Aug 12, 2022 · Before open+0.7%
Q1 2022May 6, 2022 · Before open+0.1%
Q4 2021Mar 4, 2022 · Before open+4.0%
Q3 2021Nov 5, 2021+0.3%
Quarter to Jun 30, 2021Aug 12, 2021+1.1%
Quarter to Mar 31, 2021May 7, 2021−3.3%
Quarter to Dec 31, 2020Mar 5, 2021−5.0%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (October 2014)Investor deck10 slidesOctober 2014
Investor PresentationInvestor deck15 slides

Open Decks

Financials

Annual, in TRY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue19.2B20.2B16.4B4.48B2.33B1.86B1.37B1.04B800.3M688.5M
Cost of revenue12.9B12.2B9.51B2.13B971.2M898.1M688.5M543.2M470.4M425.1M
Gross profit6.30B8.08B6.85B2.34B1.36B965.2M685.5M497.5M329.9M263.4M
Research and development1.00B813.8M1.55B163.1M74.0M80.9M39.4M35.8M28.8M12.0M
Selling, general and administrative1.56B1.95B1.30B425.3M191.4M95.8M83.0M76.4M55.9M46.6M
Operating income9.18M2.21B1.59B1.26B841.1M633.3M399.9M249.7M138.1M114.7M
Depreciation and amortization1.56B1.42B981.6M114.8M79.2M59.8M46.1M34.9M30.9M27.5M
EBITDA1.57B3.63B2.57B1.37B920.3M693.1M446.0M284.6M169.0M142.1M
Interest expense2.73B3.79B2.20B514.8M227.9M120.8M124.7M112.9M00
Income before tax-92.7M483.5M2.85B1.30B1.16B646.5M280.7M156.0M94.6M72.0M
Income tax-60.7M-11.8M-4.91M-5.32M19.6M2.04M11.6M
Net income-807.0M90.9M4.89B1.36B1.17B651.4M286.0M136.4M92.5M60.3M
Earnings per share, basic-4.030.4524.446.805.853.261.430.680.46

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents2.38B1.26B2.19B601.2M1.31B609.5M277.0M121.0M77.9M27.5M
Short-term investments1.21B1.58B2.95B734.6M269.3M86.1K
Receivables7.06B6.30B5.13B1.73B953.0M668.2M482.5M404.5M292.4M211.5M
Inventory5.43B6.19B5.92B2.18B1.04B627.8M468.4M404.2M232.4M190.1M
Current assets16.6B16.1B16.6B5.46B3.37B1.95B1.24B962.3M621.5M449.6M
Property, plant and equipment1.75B1.06B766.7M531.0M401.5M364.8M324.2M
Goodwill40.4M40.4M30.9M1.78M1.78M1.78M1.78M1.78M1.78M1.78M
Total assets37.6B38.9B32.4B8.62B5.08B3.09B2.12B1.67B1.26B1.02B
Accounts payable2.70B1.47B1.30B709.2M349.3M166.3M129.8M84.4M62.9M41.9M
Current liabilities10.1B10.00B9.99B4.02B1.63B987.4M670.5M584.1M418.7M245.4M
Long-term debt523.8M876.2M76.7M239.4M456.6M323.7M333.1M284.7M191.4M225.6M
Total liabilities11.3B11.7B11.1B4.69B2.35B1.45B1.09B922.0M651.3M504.7M
Shareholders' equity26.3B27.2B21.3B3.94B2.73B1.63B1.03B746.4M605.1M512.8M
Shares outstanding200.0M200.0M200.0M200.0M200.0M200.0M200.0M200.0M200.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations5.28B9.85B7.16B815.9M1.25B646.0M441.2M131.0M110.8M187.4M
Capital spending-2.36B-4.20B-3.69B-755.3M-337.0M-267.9M-147.3M-69.8M-77.8M-99.4M
Free cash flow2.92B5.65B3.47B-444.0M666.7M281.0M225.7M-28.1M-15.2M88.1M
Cash from investing-2.35B-739.8M-371.3M-209.0M-157.0M-113.2M-99.4M
Cash from financing802.4M171.1M53.0M-78.5M69.5M52.9M-97.1M
Dividends paid-603.6M-402.1M-173.6M-98.6M-53.4M-53.4M-53.4M-53.4M
Change in cash1.85B-739.7M1.19B-709.5M701.1M332.2M155.8M43.3M50.3M-8.89M

Open Financials

Cap table

Built by 6ix from Deva Holding A.S.’s releases

Common shares
200,019,288
Fully diluted
200,019,288

Fully diluted

LineShares
Common shares200,019,288

Share count over time

CountShares
Nov 22, 2026200,019,288

Open Cap table

Shareholders

HolderSharesValueChangeAs of
Emerging Markets Core Equity 2 Portfolio223KUS$329K−6,930Jul 31, 2026
Dimensional Emerging Markets Value Fund56,871US$83,933+14,321Jul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF48,133US$70,997No changeJul 31, 2026
The Emerging Markets Small Cap Series41,478US$61,215No changeJul 31, 2026
Dimensional Emerging Core Equity Market ETF30,956US$45,661No changeJul 31, 2026
Emerging Markets Social Core Equity Portfolio24,617US$36,331NewJul 31, 2026
Emerging Markets ex China Core Equity Portfolio15,649US$23,095NewJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF6,923US$10,211No changeJul 31, 2026
Dimensional Emerging Markets Sustainability Core 1 ETF1,317US$1,943No changeJul 31, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about Deva Holding A.S.